An Australian based Study on the Patterns of Short Acting Beta-2 Agonist (SABA) use and Its Potential Effects on Asthma Control (SABINA Australia)

03/07/2023
21/02/2024
EU PAS number:
EUPAS105682
Study
Ongoing
Documents
Study protocol
Study results
Study report
Other information